iQure Pharma
Skillman, US · Founded 2019 · Delaware corporation · 2 known investors
Biotechin /iqurepharma
Founders & leadership
PZ
Pawel ZolnierczykExecutive Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$650KraisedJun 2026 · 1 investors · OtherRule 506(b)
▶$650KraisedJun 2026 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Pawel ZolnierczykExecutive Officer
- Offering amount
- $4M
- Amount sold
- $650K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedNov 2025 · 14 investors · OtherRule 506(b)
▶$1.5MraisedNov 2025 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Pawel ZolnierczykExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $1.5M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedJan 2025 · 2 investors · OtherRule 506(b)
▶$1.4MraisedJan 2025 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Pawel ZolnierczykExecutive Officer
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$220KraisedApr 2024 · 7 investors · OtherRule 506(b)
▶$220KraisedApr 2024 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Pawel ZolnierczykExecutive Officer
- Amount sold
- $220K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.5MraisedOct 2023 · 13 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedOct 2023 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Pawel ZolnierczykExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.